Apolipoprotein E genotyping in Alzheimer's disease: National Institute on Aging/Alzheimer's Association Working Group

Lancet

Volumn 347, Issue 9008, 1996, Pages 1091-1095

  Relkin, Norman R ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

ALZHEIMER DISEASE; CONFIDENTIALITY; EMPLOYABILITY; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; GENOTYPE; HEALTH INSURANCE; HUMAN; PATIENT EDUCATION; PREDICTION; PRIORITY JOURNAL; SHORT SURVEY; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT;

EID: 0029944411     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90284-6     Document Type: Conference Paper

References (77)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci 1993; 90: 1977-81.
2. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-31.
3. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ∈4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34: 752-54.
4. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-72.
5. Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993; 342: 697-99.
6. Rebeck GW, Reiter JS, Strickland DK, et al. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993; 11: 575-80.
7. Nalbantoglu J, Gilfix BM, Bertrand P, et al. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol 1994; 36: 889-95.
8. Tsai M-S, Tangalos EG, Petersen RC, et al. Apolipoprotein E: risk factor for Alzheimer's disease. Am J Hum Genet 1994; 54: 643-49.
9. Yu C-E, Payami H, Olson JM, et al. The apolipoprotein E/C/CII gene cluster and late-onset Alzheimer disease. Am J Hum Genet 1994; 54: 631-42.
10. Zubenko GS, Stiffler S, Stabler S, et al. Association of the apolipoprotein E ∈4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am J Med Genet 1994; 54: 199-205.
11. Houlden H, Crook R, Hardy J, et al. Confirmation that familial clustering and age of onset in late onset Alzheimer's disease are determined at the apolipoprotein E locus. Neurosci Lett 1994; 174: 222-24.
12. Peacock ML, Fink JK. ApoE ∈4 allelic association with Alzheimer's disease: independent confirmation using denaturing gradient gel electrophoresis. Neurology 1994; 44: 339-41.
13. Myers RH, Schaefer EJ, Wilson PWF, et al. Apolipoprotein E ∈4 association with dementia in a population based study: the Framingham Study. Neurology 1996; 46: 673-77.
14. Anwar N, Lovestone S, Cheetham ME, et al. Apolipoprotein E-∈4 allele and Alzheimer's disease. Lancet 1993; 342: 1308-09.
15. Czech C, Monning U, Tienari PJ, et al. Apolipoprotein E-∈4 allele and Alzheimer's disease. Lancet 1993; 342: 1309-10.
16. Lucotte G, David F, Visvikis S, et al. Apolipoprotein E-∈4 allele and Alzheimer's disease. Lancet 1993; 342: 1308-09.
17. Brousseau T, Legrain S, Berr C, et al. Confirmation of the ∈4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology 1994; 44: 342-44.
18. Liddell M, Williams J, Bayer A, et al. Confirmation of association between the ∈4 allele of apolipoprotein E and Alzheimer's disease. J Med Genet 1994; 31: 197-200.
19. Lucotte G, Visvikis S, Leininger-Muler B, et al. Association of apolipoprotein E allele ∈4 with late-onset sporadic Alzheimer's disease. Am J Med Genet 1994; 54: 286-88.
20. Chartier-Harlin M-C, Parfitt M, Legrain S, et al. Apolipoprotein E, ∈4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994; 3: 569-74.
21. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 1995; 333: 1242-47.
22. Mahieux F, Couderc R, Moulignier A, et al. Apolipoprotein E4: phenotype in patients with Alzheimer's disease. Ann Neurol 1994; 35: 506.
23. Sorbi S, Nacmias B, Forleo P, et al. ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett 1994; 177: 100-02.
24. Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's diseases: population based study. BMJ 1994; 309: 636-38.
25. Basun H, Grut M, Winblad B, et al. Apolipoprotein ∈4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett 1995; 183: 32-34.
26. Noguchi S, Murakami K, Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993; 342: 737.
27. Ueki A, Kawano M, Namba Y. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett 1993; 163: 166-68.
28. Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, et al. Dose-dependent association of apolipoprotein E allele ∈4 with late-onset, sporadic Alzheimer's disease. Ann Neurol 1994; 36: 656-59.
29. Muramatsu T, Higuchi S, Arai H, et al. Apolipoprotein E ∈4 allele distribution in alcoholic dementia and in Alzheimer's disease in Japan. Ann Neurol 1994; 36: 797-99.
30. Bird TD. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view. Ann Neurol 1995; 38: 2-4.
31. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 1994; 7: 180-84.
32. Saunders AM, Schmader K, Breitner JCS, et al. Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993; 342: 710-11.
33. Nakagawa Y, Kitamoto T, Furukawa H, et al. Apolipoprotein E in Creutzfeldt-Jakob disease. Lancet 1995; 345: 68.
34. Galasko D, Saitoh T, Xia Y, et al. The apoliprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994; 44: 1950-51.
35. Martins RN, Clarnette R, Fisher C, et al. ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. Neuroreport 1995; 6: 1513-16.
36. Harrington CR, Louwagie J, Rossau R, et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types: significance for etiological theories of Alzheimer's disease. Am J Pathol 1994; 145: 1472-84.
37. Tabaton M, Rolleri M, Masturzo P, et al. Apolipoprotein E ∈4 allele frequency is not increased in progressive supranuclear palsy. Neurology 1995; 45: 1764-65.
38. Koller WC, Glatt SL, Hubble JP, et al. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann Neurol 1995; 37: 242-45.
39. Sakoda S, Kuriyama M, Osame M, et al. Apolipoprotein E-epsilon 4. Neurology 1994; 44: 2420.
40. Zhou Z, Smith JD, Greengard P, et al. Alzheimer amyloid-β peptide forms denaturant-resistant complex with type ∈3 but not type ∈4 isoform of native apolipoprotein E. Mol Med 1996; 2: 175-80.
41. Strittmatter WH, Saunders AM, Goedert M, et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci 1994; 91: 11183-86.
42. Poirer J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994; 17: 525-30.
43. Poirier J, Delisle M-C, Quinion R, et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc Natl Acad Sci 1995; 92: 12260-64.
44. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995; 37: 254-59.
45. Rebeck GW, Perls TT, West HL, et al. Reduced apolipoprotein ∈4 allele frequency in the oldest old Alzheimer patients and cognitively normal individuals. Neurology 1994; 44: 1513-16.
46. Breitner JCS, Silverman JM, Mohs RC, et al. Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early- and late-onset cases, and among male and female relatives in successive generations. Neurology 1988; 38: 207-12.
47. Farrer LA, Cupples LA, Van Duijn CM, et al. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Ann Neurol 1995; 38: 797-808.
48. Silverman JM, Li G, Zaccario ML, et al. Patterns of risk in first-degree relatives of patients with Alzheimer's disease. Arch Gen Psychiatry 1994; 51: 577-86.
49. Korten AE, Jorm AF, Henderson AS. Assessing the risk of Alzheimer's disease in first-degree relatives of Alzheimer's disease cases. Psychol Med 1993; 23: 915-23.
50. Payami H, Kaye J, Heston LL, et al. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993; 342: 738.
51. Bennett C, Crawford F, Osborne A, et al. Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's disease but is not causative. Am J Med Genet 1995; 60: 1-6.
52. Talbot C, Lendon C, Craddock N, et al. Protection against Alzheimer's disease with apoE ∈2. Lancet 1994; 343: 1432-33.
53. Smith AD, Leake A, McArthur FK, et al. Protective effect of apo E ∈2 in Alzheimer's disease. Lancet 1994; 344: 473-74.
54. Benjamin R, Johnston C, Sim E, et al. Protective effect of apo E ∈2 in Alzheimer's disease. Lancet 1994; 344: 473.
55. West HL, Rebeck GW, Hyman BT. Frequency of the apolipoprotein E ∈2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett 1994; 175: 46-48.
56. Locke PA, Conneally PM, Tanzi RE, et al. Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early- and late-onset cases. Genet Epidemiol 1995; 12: 83-92.
57. Kamboh MI, Sanghera DK, Ferrell RE, et al. APOE4 associated Alzheimer's disease risk is modified by α 1 antichymotrypsin polymorphism. Nature Genet 1995; 10: 486-88.
58. Payami H, Monte KR, Kaye JA, et al. Alzheimer's disease, apolipoprotein E and gender. JAMA 1994; 271: 1316-17.
59. Hardy J, Crook R, Perry R, et al. ApoE genotype and Down's syndrome. Lancet 1994; 343: 979-80.
60. Mayeux R, Ottman R, Maestre G, et al. Synergistic effects of traumatic head injury of apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology 1995; 45: 555-57.
61. Royston MC, Mann D, Pickering-Brown S, et al. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia. Neuroreport 1994; 5: 2583-85.
62. Wisniewski T, Morelli L, Wegiel J, et al. The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome. Ann Neurol 1995; 37: 136-38.
63. Jorm AF. The epidemiology of Alzheimer's disease and related disorders. London: Chapman and Hall, 1990.
64. Farrer LA, Brin MF, Elsas L, et al. Statement on use of apolipoprotein E testing for Alzheimer disease. JAMA 1995; 274: 1627-29.
65. Roses AD. Apolipopotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995; 38: 6-14.
66. Brodaty H. Consensus statement on predictive testing for Alzheimer disease. Alzheimer Dis Assoc Disord 1995; 9: 182-87.
67. Seshadri S, Drachman D, Lippa C. Apolipoprotein E ∈4 allele and the lifetime risk of Alzheimer's disease: what physicians know, and what they should know. Arch Neurol 1995; 52: 1074-79.
68. Annas GJ. Privacy rules for DNA databanks: protecting coded 'future diaries'. JAMA 1993; 270: 2346-50.
69. Frankel MS, Teich AH Jr, eds. Ethical and legal issues in pedigree research. Washington, DC: American Association for the Advancement of Science, 1993.
70. Kosunen O, Talasniemi S, Lehtovirta M, et al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke 1995; 26: 743-48.
71. Stengard JH, Zerba KE, Pekkanen J, et al. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995; 91: 265-69.
72. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 1995; 45: 1323-28.
73. Mayeux R, Schupf N. Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine. Am J Public Health 1995; 85: 1280-84.
74. Goate A, Chartier-Harlin M-C, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-06.
75. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754-60.
76. Levy-Lahad E, Wijsman EM, Nemens E, et al. A familial Alzheimer's disease locus on chromosome I. Science 1995; 269: 970-73.
77. Small GW, Mazziota JC, Collins MT, et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease. JAMA 1995; 273: 942-46.